A δ-cell subpopulation with pro-β cell identity contributes to efficient age-independent recovery in a zebrafish diabetes model

Abstract

Restoring damaged b-cells in diabetic patients by harnessing the plasticity of other pancreatic cells raises the questions of the efficiency of the process and of the functionality of the new Insulin-expressing cells. To overcome the weak regenerative capacity of mammals, we used regeneration-prone zebrafish to study b-cells arising following destruction. We show that most new insulin cells differ from the original b-cells as they coexpress Somatostatin and Insulin. These bihormonal cells are abundant, functional and able to normalize glycemia. Their formation in response to b-cell destruction is fast, efficient and age-independent. Bihormonal cells are transcriptionally close to a subset of d-cells that we identified in control islets and which are characterized by the expression of somatostatin 1.1 (sst1.1) and by genes essential for glucose-induced Insulin secretion in β-cells such as pdx1, slc2a2 and gck. We observed in vivo the conversion of monohormonal sst1.1-expressing cells to sst1.1+ ins+ bihormonal cells following b-cell destruction. Our findings support the conclusion that sst1.1 d-cells possess a pro-b identity enabling them to contribute to the neogenesis of Insulin-producing cells during regeneration. This work unveils that abundant and functional bihormonal cells benefit to diabetes recovery in zebrafish.

Data availability

RNA sequencing data have been deposited at NCBI GEO

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Claudio Andrés Carril Pardo

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cells, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  2. Laura Massoz

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cells, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  3. Marie A Dupont

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cells, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  4. David Bergemann

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cells, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  5. Jordane Bourdouxhe

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cells, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  6. Arnaud Lavergne

    GIGA-Genomics core facility, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  7. Estefania Tarifeño-Saldivia

    Department of Biochemistry and Molecular Biology, University of Concepción, Concepción, Chile
    Competing interests
    No competing interests declared.
  8. Christian SM Helker

    Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
    Competing interests
    No competing interests declared.
  9. Didier YR Stainier true

    Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
    Competing interests
    Didier YR Stainier, Senior editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0382-0026
  10. Bernard Peers

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cells, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  11. Marianne M Voz

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cellslls, University of Liège, Liège, Belgium
    Competing interests
    No competing interests declared.
  12. Isabelle Manfroid

    Zebrafish Development and Disease Models laboratory, GIGA-Stem Cells, University of Liège, Liège, Belgium
    For correspondence
    Isabelle.Manfroid@uliege.be
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3445-3764

Funding

Chilean National Agency for Research and Development , Becas Chile (Scholarship,72170660)

  • Claudio Andrés Carril Pardo

National Belgian Funds for Scientific Research (FRIA PhD fellowship)

  • Arnaud Lavergne

National Belgian Funds for Scientific Research (FRIA PhD fellowship)

  • Laura Massoz

National Belgian Funds for Scientific Research (EoS Program,30826052)

  • Marie A Dupont

National Belgian Funds for Scientific Research (FRIA PhD fellowship)

  • David Bergemann

National Belgian Funds for Scientific Research (EoS Program,30826052)

  • Jordane Bourdouxhe

European Regional Development Fund (Biomed Hub Technology Support,2.2.1/996)

  • Arnaud Lavergne

National Belgian Funds for Scientific Research

  • Bernard Peers

National Belgian Funds for Scientific Research

  • Isabelle Manfroid

National Belgian Funds for Scientific Research

  • Marianne M Voz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were carried out in compliance with the European Union and Belgian law and with the approval of the ULiège Ethical Committee for experiments with laboratory animals (approval numbers 14-1662, 16-1872, 19-2083, 21-2353).

Copyright

© 2022, Carril Pardo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,839
    views
  • 325
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Claudio Andrés Carril Pardo
  2. Laura Massoz
  3. Marie A Dupont
  4. David Bergemann
  5. Jordane Bourdouxhe
  6. Arnaud Lavergne
  7. Estefania Tarifeño-Saldivia
  8. Christian SM Helker
  9. Didier YR Stainier true
  10. Bernard Peers
  11. Marianne M Voz
  12. Isabelle Manfroid
(2022)
A δ-cell subpopulation with pro-β cell identity contributes to efficient age-independent recovery in a zebrafish diabetes model
eLife 11:e67576.
https://doi.org/10.7554/eLife.67576

Share this article

https://doi.org/10.7554/eLife.67576

Further reading

    1. Cell Biology
    Satoshi Ninagawa, Masaki Matsuo ... Kazutoshi Mori
    Research Advance

    How the fate (folding versus degradation) of glycoproteins is determined in the endoplasmic reticulum (ER) is an intriguing question. Monoglucosylated glycoproteins are recognized by lectin chaperones to facilitate their folding, whereas glycoproteins exposing well-trimmed mannoses are subjected to glycoprotein ER-associated degradation (gpERAD); we have elucidated how mannoses are sequentially trimmed by EDEM family members (George et al., 2020; 2021 eLife). Although reglucosylation by UGGT was previously reported to have no effect on substrate degradation, here we directly tested this notion using cells with genetically disrupted UGGT1/2. Strikingly, the results showed that UGGT1 delayed the degradation of misfolded substrates and unstable glycoproteins including ATF6α. An experiment with a point mutant of UGGT1 indicated that the glucosylation activity of UGGT1 was required for the inhibition of early glycoprotein degradation. These and overexpression-based competition experiments suggested that the fate of glycoproteins is determined by a tug-of-war between structure formation by UGGT1 and degradation by EDEMs. We further demonstrated the physiological importance of UGGT1, since ATF6α cannot function properly without UGGT1. Thus, our work strongly suggests that UGGT1 is a central factor in ER protein quality control via the regulation of both glycoprotein folding and degradation.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Senem Ntourmas, Martin Sachs ... Dominic B Bernkopf
    Research Article

    Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.